by Oracle Corporation UK Ltd
> View this now
Published on: December 26, 2012
Type of content: CASE STUDY
Length: 6 pages
As the volume of data continues to grow, many companies are finding that legacy database platforms lack the necessary scalability, agility, and performance for today’s market. Merck & Co., a global research-driven pharmaceutical company, was experiencing such extreme growth in their database that application performance was starting to suffer.
Download this case study to uncover how Merck & Co. overcame their database dilemma by implementing an innovative platform that enabled them to:
- Reduce memory utilization by 40%
- Increase system speed by 5x
- Increase efficiency
- And more.